-+ 0.00%
-+ 0.00%
-+ 0.00%
Curia partners with eXoZymes to scale up NCT manufacturing process
Share
Listen to the news
Curia partners with eXoZymes to scale up NCT manufacturing process
  • Curia Global signed an agreement with eXoZymes to support technology transfer and commercial-scale manufacturing scale-up for N-trans-caffeoyltyramine (NCT).
  • Program slated to start in Q4 2026, setting a technical roadmap for larger-scale production in 2027.
  • Work to be carried out at Curia sites in León, Spain, and Rozzano, Italy.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curia Global Inc. published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending